DrugPatentWatch Database Preview
AMOXAPINE Drug Profile
» See Plans and Pricing
When do Amoxapine patents expire, and when can generic versions of Amoxapine launch?
Amoxapine is a drug marketed by Upsher Smith Labs, Watson Labs, and Watson Pharms Teva. and is included in nine NDAs.
The generic ingredient in AMOXAPINE is amoxapine. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxapine profile page.
US ANDA Litigation and Generic Entry Outlook for Amoxapine
A generic version of AMOXAPINE was approved as amoxapine by WATSON LABS on August 28th, 1992.
Summary for AMOXAPINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 9 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 86 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,324 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AMOXAPINE at DailyMed |
Recent Clinical Trials for AMOXAPINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
| New York State Psychiatric Institute | Phase 2 |
Pharmacology for AMOXAPINE
| Drug Class | Tricyclic Antidepressant |
Medical Subject Heading (MeSH) Categories for AMOXAPINE
US Patents and Regulatory Information for AMOXAPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072943-001 | Jun 28, 1991 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Watson Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072691-004 | Aug 28, 1992 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
| Upsher Smith Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072879-001 | Jun 28, 1991 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072421-001 | May 11, 1989 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Watson Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072691-001 | Aug 28, 1992 | RX | No | Yes | Start Trial | Start Trial | Start Trial | ||||
| Upsher Smith Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072944-001 | Jun 28, 1991 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Upsher Smith Labs | AMOXAPINE | amoxapine | TABLET;ORAL | 072878-001 | Jun 28, 1991 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
